Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CRISPR Therapeutics AG | 22,000 | reported | 06 Aug 2025 | tx 7+111,000 |
| Inozyme Pharma, Inc. | 0 | reported | 01 Jul 2025 | tx 20+1,782,626−747,182 |
| Ra Pharmaceuticals, Inc. | 0 | reported | 02 Apr 2020 | tx 15+744,334−1,488,817 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Aug 2025 | PURCHASE | CRISPR Therapeutics AG | 20,000 | 57.03 USD | |
| 01 Jul 2025 | TENDER | Inozyme Pharma, Inc. | 43,861 | 4.00 USD | |
| 01 Jul 2025 | OTHER | Inozyme Pharma, Inc. | 400,000 | — | deriv |
| 01 Jul 2025 | OTHER | Inozyme Pharma, Inc. | 86,979 | — | deriv |
| 01 Jul 2025 | OTHER | Inozyme Pharma, Inc. | 150,000 | — | deriv |
| 25 Jun 2025 | GRANT_AWARD | Inozyme Pharma, Inc. | 2,815 | 0.74 USD | |
| 05 Jun 2025 | GRANT_AWARD | CRISPR Therapeutics AG | 13,000 | 0.00 USD | deriv |
| 01 Apr 2025 | EXERCISE | Inozyme Pharma, Inc. | 25,000 | — | |
| 02 Apr 2025 | SALE | Inozyme Pharma, Inc. | 8,819 | 0.89 USD | |
| 01 Apr 2025 | EXERCISE | Inozyme Pharma, Inc. | 25,000 | 0.00 USD | deriv |
| 11 Mar 2025 | GRANT_AWARD | Inozyme Pharma, Inc. | 400,000 | 0.00 USD | deriv |
| 11 Mar 2025 | GRANT_AWARD | Inozyme Pharma, Inc. | 100,000 | 0.00 USD | deriv |
| 30 Sept 2024 | GRANT_AWARD | Inozyme Pharma, Inc. | 1,710 | 4.45 USD | |
| 30 May 2024 | GRANT_AWARD | CRISPR Therapeutics AG | 13,000 | 0.00 USD | deriv |
| 01 Apr 2024 | EXERCISE | Inozyme Pharma, Inc. | 25,000 | — | |
| 02 Apr 2024 | SALE | Inozyme Pharma, Inc. | 7,523 | 6.94 USD | |
| 01 Apr 2024 | EXERCISE | Inozyme Pharma, Inc. | 25,000 | 0.00 USD | deriv |
| 13 Mar 2024 | GRANT_AWARD | Inozyme Pharma, Inc. | 300,000 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | CRISPR Therapeutics AG | 13,000 | 0.00 USD | deriv |
| 01 Apr 2023 | GRANT_AWARD | Inozyme Pharma, Inc. | 100,000 | 0.00 USD | deriv |
| 01 Apr 2023 | GRANT_AWARD | Inozyme Pharma, Inc. | 800,000 | 0.00 USD | deriv |
| 10 Jun 2022 | GRANT_AWARD | Inozyme Pharma, Inc. | 9,367 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | CRISPR Therapeutics AG | 12,000 | 0.00 USD | deriv |
| 23 Jun 2021 | GRANT_AWARD | Inozyme Pharma, Inc. | 9,367 | 0.00 USD | deriv |
| 10 Jun 2021 | GRANT_AWARD | CRISPR Therapeutics AG | 10,000 | 0.00 USD | deriv |